Carbapenem resistance in community-acquired urinary tract infections caused by <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i> in Morocco: a multicentre study (January 2022-December 2023): '<b>Carbapenem resistance in community UTIs in Morocco'</b>. [PDF]
Khazaz A +9 more
europepmc +1 more source
Clinical emergence of a novel sequence type (ST3672) NDM-1-producing <i>Vibrio parahaemolyticus</i> in foodborne disease. [PDF]
Ni C +8 more
europepmc +1 more source
Molecular Epidemiology of NDM-Producing <i>Escherichia coli</i> Isolates in Croatia from March 2023 to March 2024. [PDF]
Ujević J +3 more
europepmc +1 more source
Comparative <i>in vitro</i> efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France. [PDF]
Emeraud C, Dutkiewicz M, Dortet L.
europepmc +1 more source
Treatment of Post-Neurosurgical Ventriculitis and Scalp Infection Caused by Klebsiella pneumoniae Carbapenemase and New Delhi Metallo-β-Lactamase Co-Producing Carbapenem-Resistant Klebsiella pneumoniae: A Case Report. [PDF]
Ma XR +6 more
europepmc +1 more source
Confronting <i>bla</i> <sub>NDM-5</sub> in <i>Salmonella Typhi</i>: From Molecular Epidemiology, Resistance Mechanism to Clinical Management. [PDF]
Guo X, Wu J, Li K.
europepmc +1 more source
In vitro activity of aztreonam/avibactam and comparators against Enterobacterales isolates from patients with hospital-acquired pneumonia, ventilator-associated pneumonia, and complicated intra-abdominal infections (ATLAS, 2021-2022). [PDF]
Yang Q +7 more
europepmc +1 more source
Convergence of Carbapenem and Colistin Resistance in Intestinal <i>Escherichia coli</i> ST167/ST2659 Driven by IncX3 <i>bla</i> <sub>NDM-5</sub> and IncI2-Associated <i>Mcr-1.1</i> Mobility. [PDF]
Bao L +7 more
europepmc +1 more source

